CA2086267A1 - Derives et conjugues derives de la cyclosporine - Google Patents

Derives et conjugues derives de la cyclosporine

Info

Publication number
CA2086267A1
CA2086267A1 CA 2086267 CA2086267A CA2086267A1 CA 2086267 A1 CA2086267 A1 CA 2086267A1 CA 2086267 CA2086267 CA 2086267 CA 2086267 A CA2086267 A CA 2086267A CA 2086267 A1 CA2086267 A1 CA 2086267A1
Authority
CA
Canada
Prior art keywords
cyclosporin
derivative
methyl
acetyl
intact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2086267
Other languages
English (en)
Inventor
Argyrios Margaritis
Patricia Alison Paprica
Nils Overgaard Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Ontario
Original Assignee
University of Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Ontario filed Critical University of Western Ontario
Priority to CA 2086267 priority Critical patent/CA2086267A1/fr
Publication of CA2086267A1 publication Critical patent/CA2086267A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
CA 2086267 1992-12-24 1992-12-24 Derives et conjugues derives de la cyclosporine Abandoned CA2086267A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2086267 CA2086267A1 (fr) 1992-12-24 1992-12-24 Derives et conjugues derives de la cyclosporine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2086267 CA2086267A1 (fr) 1992-12-24 1992-12-24 Derives et conjugues derives de la cyclosporine

Publications (1)

Publication Number Publication Date
CA2086267A1 true CA2086267A1 (fr) 1994-06-25

Family

ID=4150908

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2086267 Abandoned CA2086267A1 (fr) 1992-12-24 1992-12-24 Derives et conjugues derives de la cyclosporine

Country Status (1)

Country Link
CA (1) CA2086267A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US20160200767A1 (en) * 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
US9765119B2 (en) 2001-10-19 2017-09-19 Aurinia Pharmaceuticals Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
WO2018159841A1 (fr) * 2017-03-03 2018-09-07 株式会社資生堂 Nouveau composé, réactif de dérivation par fluorescence comprenant ledit nouveau composé, procédé de résolution optique d'isomère optique d'acide aminé dans lequel ledit nouveau composé est utilisé et acide aminé dérivé par fluorescence

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9765119B2 (en) 2001-10-19 2017-09-19 Aurinia Pharmaceuticals Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
USRE48226E1 (en) 2001-10-19 2020-09-29 Aurinia Pharmaceuticals Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
US10472394B2 (en) 2001-10-19 2019-11-12 Aurinia Pharmaceuticals Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
US7538084B2 (en) 2003-03-17 2009-05-26 Amr Technology, Inc. Cyclosporins
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
US7632807B2 (en) 2004-10-06 2009-12-15 Albany Molecular Research, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US9914755B2 (en) * 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
US20160200767A1 (en) * 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
WO2018159841A1 (fr) * 2017-03-03 2018-09-07 株式会社資生堂 Nouveau composé, réactif de dérivation par fluorescence comprenant ledit nouveau composé, procédé de résolution optique d'isomère optique d'acide aminé dans lequel ledit nouveau composé est utilisé et acide aminé dérivé par fluorescence

Similar Documents

Publication Publication Date Title
CN1218958C (zh) 活性范围改善的环孢菌素
US5990273A (en) Synthesis of cyclic peptides
JP4477777B2 (ja) 新規シクロスポリン
JP3358827B2 (ja) N−アシル−s−(2−ヒドロキシアルキル)システイン
US4507235A (en) Method for preparing peptides and intermediate products
EP0253190B1 (fr) Analogues de la tuftsine partiellement rétro-inversés, leur méthode de préparation et compositions pharmaceutiques les contenant
CA2086267A1 (fr) Derives et conjugues derives de la cyclosporine
US5977302A (en) Liquid phase process for the preparation of GnRH peptides
JPH09502423A (ja) 1‐デアミノ‐8‐d‐アルギニン・バソプレッシンの製造法
CZ280870B6 (cs) Nový polypeptid a z něho připravené anti-HIV léčivo
JPH10500123A (ja) アミノスルホン酸の誘導体、プソイドペプチドの合成における同誘導体の利用、およびその製造法
JP2020033349A (ja) 環式ウンデカペプチドの製造方法
LU85710A1 (fr) Nouveaux derives de la gonadoliberine et procede pour leur preparation
CA2157047C (fr) Aureobasidines
HU208838B (en) Method for producing peptones containing aza aminoacides by means of solid-phase synthesis
KR100844520B1 (ko) Lhrh 길항제 합성용 중간체, 그 제조 방법 및lhrh 길항제의 제조 방법
Paprica et al. Preparation of novel cyclosporin A derivatives
JP2002532466A (ja) α−ヒドロキシ−β−アミノ酸およびアミド誘導体の合成のための方法
EP0277561B1 (fr) Dérivé de l'arginine, procédé pour sa préparation et son utilisation dans la synthèse de peptides
RU2126419C1 (ru) Аглюкодальбагептиды и/или их соли с кислотами или основаниями, или их внутренние соли, способ получения, фармацевтическая композиция
DE10215336A1 (de) N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung
Lee et al. CYCLIC PEPTIDES: II. Synthesis of a Cyclodepsipeptide, Protodestruxin
Cadicamo et al. Investigation of the synthetic route to pepstatin analogues by SPPS using O‐protected and O‐unprotected statine as building blocks
US7442683B2 (en) Cyclic peptide
KR100272310B1 (ko) 액상 1-데아미노-8-d-아르기닌 바소프레신 아세테이트 합성법

Legal Events

Date Code Title Description
FZDE Dead